ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1419	National Cancer Institute	Html	en	Lung Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for lung cancer.	lung cancer screening 0.756773 initial screening test 0.3898 LDCT lung cancer 0.431859 sputum cytology 0.442562 U.K. Lung Cancer 0.42482 negative screening test 0.411746 lung cancer 0.9987 lung cancer mortality. 0.430481 current smokers 0.386204 intense screening regimen 0.386147 Early Lung Cancer 0.463536 chest imaging 0.420806 positive screening result 0.397336 lung abnormalities 0.397732 excess lung cancer 0.416122 Lung Screening Trial 0.503515 group 0.383474 intervention arm 0.382743 lung cancer problem 0.42431 positive screening test 0.414453 screening phase 0.386735 lung cancers 0.45033 major lung abnormality 0.402566 LDCT screening 0.417092 lung cancer cases 0.428353	randomized Danish Lung 0.39566 positive screening tests 0.398319 chest radiographic screening 0.412733 cancer screening program 0.414425 lung component 0.385589 Danish Lung Cancer 0.447818 Screening pilot trial 0.393797 Lung Cancer Action 0.443317 participants 0.389736 National Lung Screening 0.500437 Lung Cancer Detection 0.423833 CT screening program 0.391863 Randomized Lung Cancer 0.430455 small lung cancers 0.401362 screening exams 0.383361 lung cancer. 0.390552 lung cancer deaths 0.457228 PLCO Cancer Screening 0.408534 lung cancer death 0.470333 Mayo Lung Project 0.426524 screening test 0.418941 lung cancer mortality 0.632713 lung cancer incidence 0.423847 Cancer Screening Trial 0.513616	CLICK HERE
1448	National Cancer Institute	Html	en	Bladder and Other Urothelial Cancers Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for bladder cancer.	bladder cancers 0.459113 individual developing bladder 0.462762 bladder cancer patients 0.501836 Cancer Statistics Review 0.390961 transitional cell carcinoma 0.372436 American Cancer Society 0.389675 bladder cancer 0.911425 Bladder histological changes 0.431525 bladder cancer outcome 0.469139 bladder cancer cases 0.467655 Malignant bladder tumors 0.429947 bladder neoplasms 0.417201 bladder tumours 0.413309 repetitive hematuria screening 0.375531 bladder cancer risk 0.493294 bladder tumors 0.476533 superficial bladder cancer 0.470192 hematuria screening studies 0.380947 bladder toxicity 0.421878 Natl Cancer Inst 0.460204 newly diagnosed bladder 0.471386 Bladder Cancer Group 0.465328 metastatic bladder cancer 0.508614 neuropathic bladder 0.420139 et al. 0.424244	SEER Cancer Statistics 0.388904 bladder carcinogenesis 0.425543 bladder wall 0.415168 bladder cancer mortality 0.489217 bladder tumor antigen 0.4299 bladder cancer. 0.44027 urothelial bladder cancer 0.487451 Cancer Epidemiol Biomarkers 0.435283 urothelial cancer 0.372416 smoking related bladder 0.437945 PUBMED Abstract 0.468199 hematuria home screening 0.413339 bladder cancer case-fatality 0.488876 invasive bladder cancer 0.504621 Superficial bladder tumor 0.43348 National Cancer Institute 0.389198 Bladder cancer incidence 0.470999 bladder malignancies 0.448894 Epidemiol Biomarkers Prev 0.405245 bladder tumor incidence 0.430849 Bladder cancer screening 0.490371 Abstract 0.469966 recurrent bladder tumors 0.444789 urinary bladder cancer 0.487624	CLICK HERE
1542	National Cancer Institute	Html	en	Uterine Sarcoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of uterine sarcomas.	cancer treatment 0.326283 cancer spreads 0.27392 body 0.30595 PDQ cancer information 0.340432 clinical trial search 0.337812 uterus 0.36876 metastatic uterine sarcoma 0.28805 clinical trials 0.632813 cancer information summary 0.313263 clinical trial 0.463679 Transvaginal ultrasound exam 0.270971 patients 0.291529 Recurrent uterine sarcoma 0.312941 total abdominal hysterectomy 0.33979 treatment clinical trial 0.271689 NCI PDQ cancer 0.280198 Treatment Option Overview 0.316082 radiation therapy 0.397408 Treatment Editorial Board 0.278942 General information 0.276617 general cancer information 0.27165 treatment 0.476479 uterine sarcoma cells 0.294562 NCI-supported cancer 0.289424 cancer cells 0.449324	Cancer Information Service 0.272134 Uterine Sarcoma Treatment 0.298886 Option Overview section 0.306678 Uterine Cancer Home 0.286123 treatment clinical trials 0.296817 National Cancer Institute 0.35406 new treatment 0.296864 uterine sarcoma 0.941913 Uterine Sarcoma section 0.285791 diagnose uterine sarcoma 0.300059 PDQ summary 0.281429 uterine sarcoma spreads 0.28676 cancer clinical trials 0.348942 stage 0.302932 Endometrial Cancer Treatment 0.295433 high-energy sound waves 0.275392 fallopian tubes 0.310914 Tissue Sarcoma Treatment 0.291575 treatment options 0.275101 cancer information summaries 0.270428 comprehensive cancer information 0.27068 cancer 0.782046 information 0.353338 standard treatment 0.299992	CLICK HERE
2013	National Cancer Institute	Html	es	Aspectos generales de los exámenes de detección del cáncer (PDQ®)–Versión para pacientes	Información sobre la medición de la eficacia de los exámenes de detección del cáncer y la evaluación de la solidez de las pruebas obtenidas en estudios de investigación de detección del cáncer.	suficiente información 0.640426 riesgos.Algunos exámenes 0.948845 posibles factores 0.658466 End Results 0.782283 siguientes aspectos 0.657281 cabo ensayos 0.656668 ¿Los exámenes 0.83489 siguientes tipos 0.726625 efecto secundario adverso 0.681584 cuánto tiempo 0.658052 grupo pacientes 0.645515 información ayuda 0.635388 National Cancer Institute 0.643177	siguientes riesgos 0.629124 Instituto Nacional 0.984309 antecedentes familiares 0.663533 suficientes pruebas 0.65243 Physician Data Query 0.768953 Estados Unidos 0.927922 menor tiempo 0.639093 única razón 0.651582 posibles beneficios 0.675509 determinada enfermedad 0.640319 cuáles pruebas 0.82218 términos riesgo 0.746808 PDQ Aspectos 0.65214	CLICK HERE
2056	National Cancer Institute	Html	es	Píldoras anticonceptivas y el riesgo de cáncer	Hoja informativa acerca de la investigación sobre el riesgo de padecer cáncer de seno, de cérvix, de hígado y de ovarios por el uso de anticonceptivos orales.	oral contraceptives 0.31866 associated with 0.302278 hereditary ovarian cancer 0.307224 anticonceptivos orales 0.994735 combined estrogen-progestogen 0.301637 brca1 or brca2 0.301383 Carrier Cohort Study 0.301448 Disease Control 0.30169 tumores benignos 0.304773 femeninas naturales estrógeno 0.301612 Child Health 0.30166 Steroid Hormone Study 0.30142 IARC Monographs 0.301103 collaborative reanalysis 0.302305 ovarian cancer 0.328123 IARC Working Group 0.301458 Estados Unidos 0.301544 cervical cancer 0.319583 Hormonas Esteroides 0.301394 PubMed Abstract 0.41376 menor riesgo 0.304581 hormonal factors 0.3025 BRCA2 mutation 0.301911 Ovarian Cancer Clinical 0.303961 altas concentraciones 0.302166	efecto protector 0.30213 BRCA2 mutation carriers 0.301397 anticonceptivo oral combinado” 0.302358 alto riesgo 0.304148 Carcinogenic Risks 0.301908 Hunter DJ 0.301541 oral contraception 0.301256 Endocrine-Related Cancer 0.303484 benign liver tumours 0.301157 Epidemiology Biomarkers 0.302164 Cancer Research 0.303353 epidemiological studies 0.304291 National Institute 0.301484 estrogen-progestogen menopausal therapy 0.3011 hormonal contraceptives 0.302747 Human Development 0.301691 IARC commitment 0.301082 breast cancer 0.314784 cuello uterino 0.311204 associated with oral-contraceptive 0.301437 Cancer Institute 0.303378 Colditz GA 0.301768 Combined estrogen-progestogen contraceptives 0.301471 prospective study 0.301048	CLICK HERE
2074	National Cancer Institute	Html	es	Lunares comunes, nevos displásicos y el riesgo de melanoma	Hoja informativa que trata de los lunares y de cómo algunos de ellos pueden relacionarse con el melanoma, el cual es el tipo más grave de cáncer de piel. La hoja informativa incluye fotos de las diferencias entre los lunares y el cáncer y habla de los factores de riesgo para el melanoma.	cutaneous melanoma 0.625563 American Medical Association 0.446245 American Academy 0.427461 Titus-Ernstoff L 0.428273 Farber MJ 0.430084 Retrieved July 0.486153 Cancer Statistics Review 0.452828 melanoma diagnosis 0.625391 raros casos 0.429111 SEER Web site 0.451878 Halpern A 0.427294 American Cancer Society 0.542367 Noone AM 0.428963 Holly EA 0.427203 Warycha MA 0.428668 National Cancer Institute 0.451063 Does Melanoma Look 0.709416 color café 0.453426 quemaduras solares 0.441604 estadounidenses —más 0.43587 atypical moles 0.48786 antecedentes familiares 0.432287 más anchos 0.493483	Family Physician 0.42998 página what does 0.683972 médicos familiares 0.43414 lámparas solares 0.871559 central risk factor 0.448185 patient with 0.429841 years beyond 0.429706 Rigel DS 0.428483 Estados Unidos 0.428522 Krapcho M 0.428389 PubMed Abstract 0.979256 Cyr PR 0.430249 única forma 0.527641 piel al sol 0.463391 Mole Look Like 0.64852 early melanoma detection 0.640669 página luz solar del nci 0.453944 Acta Dermato Venereologica 0.450034 Goodson AG 0.428558 Perry AE 0.427784 Cancer Journal 0.432434 Look Like 0.678163	CLICK HERE
3422	National Cancer Institute	Html	es	Reconstrucción del seno después de una mastectomía	Hoja informativa que describe la reconstrucción del seno (mama) después de una mastectomía. Contiene información sobre las opciones quirúrgicas, los cuidados de seguimiento y los exámenes de detección del cáncer de seno después de la reconstrucción.	cirugía abdominal 0.39888 ley whcra 0.35286 Nipple-sparing mastectomy—is it 0.332063 Cordeiro PG 0.320216 colgajo siep 0.393996 Colgajo TRAM 0.39889 suficiente piel 0.387487 largo plazo 0.34858 large cell lymphoma 0.395571 reconstruction following surgery 0.356853 Reconstructive Surgery 0.417753 Colgajo SGAP 0.397479 Colgajo PAP 0.399861 Colgajo Latissimus 0.401399 PubMed Abstract 0.945047 Colgajo TUG 0.398937 colgajo diep 0.587224 Surgical Oncology Clinics 0.338406 Cirugía oncoplástica.  0.339864 La Cruz L 0.324776 NCI titulada Mamografías 0.32023 breast reconstruction 0.705756 colgajo igap 0.469394 pequeños trozos 0.3196 suficiente tejido 0.3777	colgajos ld 0.342761 Colgajo SIEA 0.398955 Da Lio A 0.329732 implantes de solución 0.348682 reconstruction after surgery 0.366752 therapy implications following 0.337385 suficiente volumen 0.324436 reconstrucción retardada 0.559365 Breast reconstruction after 0.445489 reconstruction after mastectomy 0.350953 Petit JY 0.31974 Breast Disease 0.377661 Cancer Rights Act 0.334748 Reviews Clinical Oncology 0.3359 oncoplastic breast-conserving surgery 0.341614 Total skin sparing 0.332343 técnica llamada 0.357673 sensibilidad conforme crecen y 0.339464 anaplastic large cell 0.394345 New England Journal 0.330568 ¿qué tipo 0.325566 physical therapy 0.407423 systematic reviews 0.354768 Surgical Oncology 0.355698	CLICK HERE
3675	National Cancer Institute	Html	en	Data Submission Under the Genomic Data Sharing (GDS) Policy	Information for intramural, extramural, and non-NIH funded investigators looking to submit study data under the Genomic Data Sharing (GDS) Policy.	data instruments 0.389578 Different submission requirements 0.358856 Different data types 0.458311 data 0.914172 N/A Arrays 0.352863 Institutional Certification 0.390929 data use limitations 0.365334 phenotype data 0.455331 DNA sequence data 0.507348 clinical information 0.351464 N/A .BAM Arrays 0.717463 common data elements 0.45555 NCI intramural research 0.372571 RNAseq data 0.381683 submission process 0.341088 SNP array data 0.440533 Data reuse 0.406127 genomic data 0.788599 genomic program administrator 0.366093 controlled-access genomic data 0.507551 Raw data 0.388186 bisulfite sequencing data 0.488737 data sharing plan 0.431561 scientific review 0.378953	basis N/A .TXT 0.57172 GWAS data 0.384745 data standards 0.487591 published table 0.34424 human genomic data 0.471234 additional research questions 0.363874 data processing 0.449487 GDS policy-covered research 0.360223 human sample data 0.554048 GDS website 0.358009 DNA methylation data 0.435253 NIH data repositories 0.466908 minimizes potential errors 0.345345 data generation 0.367981 Developing Data Sharing 0.429887 exposure data 0.441991 well-documented data standards 0.480779 genomic data—such 0.394593 data submission 0.621641 data release 0.391289 NIH National Center 0.357378 genomic data submissions 0.597871 N/A .BAM NGS 0.52976	CLICK HERE
16776	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de Cancell/Cantron/Protocel como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Questionable methods 0.583285 NCI Tumor Cell 0.253187 Alternative Cancer Treatment 0.949939 Cancell Alternative Cancer 0.909029 physiological consequences 0.221271 Dills WL Jr 0.236274 Pedersen PL 0.220212 James V 0.220328 CA Cancer 0.715566 Instituto Nacional 0.460523 Tumor Cell Line 0.306478 Livingston-Wheeler therapy 0.223682 nombre cancell 0.23058 Estados Unidos 0.337461 mutational events that 0.237295 Cassileth BR 0.27252 Complementary Therapies 0.275875 tumour glycolysis 0.221381 Oncogenic alterations 0.222154 NCI-60 DTP Human 0.237422 Eastern District 0.221187 WW Norton 0.271304 Bioenerg Biomembr 0.223121 peso promedio 0.220355 District Court 0.221556	Alternative Medicine Handbook 0.357021 Edmund J 0.22088 United States 0.221128 bacteria p 0.221477 Semenza GL 0.221681 diabetes mellitus 0.223111 llamó entelev 0.224971 tipo cancell 0.228779 vía oral 0.22206 Winter Works 0.543066 Trends Biochem Sci 0.237977 critical role 0.221303 Dang CV 0.220582 Mathupala SP 0.220471 National Cancer Institute 0.327107 Aberrant glycolytic metabolism 0.237912 Permanent Injunction 0.223017 New York 0.262714 accessed april 0.557875 Cell Line Screen 0.307726 Physician Data Query 0.23188 Complete Reference Guide 0.33124 células primitivas resultantes 0.275971 Máxima concentración 0.230742	CLICK HERE
16861	National Cancer Institute	Html	es	Terapia Gerson (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la terapia Gerson como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	múltiples detalles 0.301338 Centro Nacional 0.302469 New Hampshire Avenue 0.301732 Drug Administration 0.301078 NCI Best Case 0.303308 Max B 0.30156 datos bibliográficos pubmed 0.30187 cuerpo suficientes vitaminas 0.303678 Vitaminas A 0.301419 siguientes preguntas 0.30102 National Cancer Institute 0.302137 siguientes riesgos 0.301292 vitamina b12 0.301563 alto contenido 0.301449 Instituto Nacional 0.314894 Gerson Research Organization 0.308778 Salud Complementaria 0.303978 Visuals Online 0.301269	complementarias revisa 0.301833 PDQ Terapia Gerson 0.311186 Physician Data Query 0.307427 comidas vegetarianas 0.301548 coenzima q10 0.304748 Estados Unidos 0.316664 enzimas pancreáticas 0.305305 libre uso 0.301348 página manejo 0.301179 ¿El tratamiento 0.302348 suficiente potasio 0.301916 ¿Los beneficios 0.301092 juntos cam 0.301043 numerosos detalles 0.301552 Series Program 0.301073 terapia gerson 0.988974 medicina complementaria 0.349955	CLICK HERE